Renal cell carcinoma deep sequencing: recent developments.
about
The role of aberrant VHL/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma.Renal cell cancer: overview of the current therapeutic landscape.VEGF/VEGFR2 and PDGF-B/PDGFR-β expression in non-metastatic renal cell carcinoma: a retrospective study in 1,091 consecutive patientsPapillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study.Cellular effects induced by 17-β-estradiol to reduce the survival of renal cell carcinoma cells.Proliferation inhibition and the underlying molecular mechanisms of microRNA-30d in renal carcinoma cells.
P2860
Renal cell carcinoma deep sequencing: recent developments.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Renal cell carcinoma deep sequencing: recent developments.
@en
type
label
Renal cell carcinoma deep sequencing: recent developments.
@en
prefLabel
Renal cell carcinoma deep sequencing: recent developments.
@en
P2860
P1476
Renal cell carcinoma deep sequencing: recent developments.
@en
P2093
Kyle Furge
Leslie J Farber
P2860
P2888
P304
P356
10.1007/S11912-012-0230-3
P50
P577
2012-06-01T00:00:00Z
P6179
1030654083